Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 391 AL 405

Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?

Manly JJ, Deters KD.

JAMA. 2023 Aug 8;330(6):510-511. doi: 10.1001/jama.2023.11704.

Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus

Pelle MC, Zaffina I, Giofrè F, Pujia R, Arturi F.

Int J Mol Sci. 2023 Jul 11;24(14):11301. doi: 10.3390/ijms241411301.

The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids

Bäckström T, Turkmen S, Das R, Doverskog M, Blackburn TP.

J Intern Med. 2023 Sep;294(3):281-294. doi: 10.1111/joim.13705. Epub 2023 Jul 30.

Does repetitive transcranial magnetic stimulation improve cognitive function in age-related neurodegenerative diseases? A systematic review and meta-analysis

Miller A, Allen RJ, Juma AA, Chowdhury R, Burke MR.

Int J Geriatr Psychiatry. 2023 Aug;38(8):e5974. doi: 10.1002/gps.5974.

Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic

Lewis A, Gupta A, Oh I, Schindler SE, Ghoshal N, Abrams Z, Foraker R, Snider BJ, Morris JC, Balls-Berry J, Gupta M, Payne PRO, Lai AM.

Neurology. 2023 Oct 3;101(14):e1424-e1433. doi: 10.1212/WNL.0000000000207674. Epub 2023 Aug 2.

Dance movement therapy for dementia

Karkou V, Aithal S, Richards M, Hiley E, Meekums B.

Cochrane Database Syst Rev. 2023 Aug 7;8(8):CD011022. doi: 10.1002/14651858.CD011022.pub3.

Targeting impaired nutrient sensing via the sirtuin pathway with novel compounds to prevent or treat dementia: A systematic review

Matysek A, Sun L, Kimmantudawage SP, Feng L, Maier AB.

Ageing Res Rev. 2023 Sep;90:102029. doi: 10.1016/j.arr.2023.102029. Epub 2023 Aug 6.

Neurovascular glial unit: A target of phytotherapy for cognitive impairments

Chen L, Zhen Y, Wang X, Wang J, Zhu G.

Phytomedicine. 2023 Oct;119:155009. doi: 10.1016/j.phymed.2023.155009. Epub 2023 Aug 2.

Antiseizure Medications in Alzheimer's Disease from Preclinical to Clinical Evidence

Bosco F, Guarnieri L, Rania V, Palma E, Citraro R, Corasaniti MT, Leo A, De Sarro G.

Int J Mol Sci. 2023 Aug 10;24(16):12639. doi: 10.3390/ijms241612639.

[Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer's Patients: A Prospective Comparative Study]

Selezneva ND, Gavrilova SI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(8):90-97. doi: 10.17116/jnevro202312308190.

Emerging diagnostics and therapeutics for Alzheimer disease

Self WK, Holtzman DM.

Nat Med. 2023 Sep;29(9):2187-2199. doi: 10.1038/s41591-023-02505-2. Epub 2023 Sep 4.

Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease

Kurkinen M.

Adv Clin Exp Med. 2023 Sep;32(9):943-947. doi: 10.17219/acem/171379.

Interventions Within the Scope of Occupational Therapy to Improve Cognitive Performance for Individuals with Dementia and Mild Cognitive Impairment (2018-2022)

Metzger L, Henley L, Smallfield S, Green M, Rhodus EK.

Am J Occup Ther. 2023 Mar 1;77(Suppl 1):7710393260. doi: 10.5014/ajot.2023.77S10026.

Prioritizing Community-Based Care for People With Alzheimer's Disease and Related Dementias in Ethnically Diverse Communities: The Time Is Now

Murali KP, Sadarangani TR.

Res Gerontol Nurs. 2023 Sep-Oct;16(5):214-216. doi: 10.3928/19404921-20230906-01. Epub 2023 Sep 1.

Effects of lithium on serum Brain-Derived Neurotrophic Factor in Alzheimer's patients with agitation

Deliyannides DA, Graff JA, Niño I, Lee S, Husain MM, Forester BP, Crocco E, Vahia IV, Devanand DP.

Int J Geriatr Psychiatry. 2023 Sep;38(9):e6002. doi: 10.1002/gps.6002.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias